LEVEL OF HEPATITIS B SURFACE ANTIGEN AND NOT HBV DNA LEVEL AFTER HBeAg SEROCLEARANCE IS PREDICTIVE OF HBsAg SEROCLEARANCE

被引：0
|
作者：
Fung, J. [1 ]
Lai, C. -L. [1 ]
Wong, D. K. [1 ]
Seto, W. -K. [1 ]
Kopaniszen, M. [1 ]
Yuen, M. -F. [1 ]
机构：
[1] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)60841-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P679
引用
收藏
页码：S295 / S295
页数：1
相关论文
共 50 条
  • [41] A CLINICALLY APPLICABLE SCORING SYSTEM FOR PREDICTING HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE AFTER TREATMENT-INDUCED HEPATITIS B E-ANTIGEN SEROCLEARANCE IN CHRONIC HEPATITIS B PATIENTS
    Wang, L.
    Cheng, K.
    Chen, Y.
    Yang, Y.
    Duan, X. M.
    Duan, Z. P.
    VALUE IN HEALTH, 2018, 21 : S62 - S62
  • [42] A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance
    Yang, Hyun
    Bae, Si Hyun
    Nam, Heechul
    Lee, Hae Lim
    Lee, Sung Won
    Yoo, Sun Hong
    Song, Myeong Jun
    Kwon, Jung Hyun
    Nam, Soon Woo
    Choi, Jong Young
    Yoon, Seung Kew
    Jang, Jeong Won
    JOURNAL OF HEPATOLOGY, 2022, 77 (03) : 632 - 641
  • [43] Early hepatitis B surface antigen seroclearance after commencement of antiviral treatment in patients with de novo HBV reactivation
    Lee, Hae Lim
    Jang, Jeong Won
    Han, Ji Won
    Lee, Sung Won
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    HEPATOLOGY, 2016, 64 : 877A - 877A
  • [44] Clinical outcomes after spontaneous and nucleos(t)ide analogues (NUCs)-treated hepatitis B surface antigen(HBsAg) seroclearance in chronic HBV infection are favourable
    Li, Xiana-Yong
    Zhu, Changhao
    You, Xu
    Wu, Yuankai
    Chong, Yutian
    HEPATOLOGY, 2016, 64 : 901A - 901A
  • [45] ANTIVIRAL THERAPY AND RISK FOR HEPATOCELLULAR CARCINOMA AFTER HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE
    Lee, Han Ah
    Kim, Seung Up
    Kim, Beom Kyung
    Ahn, Sang Hoon
    Lee, Hyun Woong
    Kim, Ja Kyung
    Sinn, Dong Hyun
    Seo, Yeon Seok
    HEPATOLOGY, 2023, 78 : S449 - S450
  • [46] Predictive Factors Associated with Hepatocellular Carcinoma Incidence and Mortality after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Kobayashi, Masahiro
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    HEPATOLOGY, 2018, 68 : 133A - 134A
  • [47] A RISK PREDICTION MODEL FOR HEPATOCELLULAR CARCINOMA AFTER HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE
    Yang, Hyun
    Jang, Jeong Won
    Bae, Si Hyun
    Nam, Heechul
    Lee, Hae Lim
    Lee, Sung Won
    Yoo, Sun Hong
    Song, Myeong Jun
    Kwon, Jung Hyun
    Lee, Ahlim
    Nam, Soon Woo
    Choi, Jong Young
    Yoon, Seung Kew
    HEPATOLOGY, 2022, 76 : S238 - S238
  • [48] Reply to: "Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance"
    Yip, Terry Cheuk-Fung
    Chan, Henry Lik-Yuen
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    JOURNAL OF HEPATOLOGY, 2018, 68 (01) : 208 - 209
  • [49] Hepatitis B surface antigen seroclearance is uncommon but durable in the long run
    Yip, Terry Cheuk-Fung
    Brunetto, Maurizia Rossana
    HEPATOLOGY, 2024, 79 (06) : 1258 - 1260
  • [50] PDCD1 methylation status predicts Hepatitis B Surface antigen seroclearance in HBV reactivation
    Islam, Mojahidul
    Vyas, Ashish K.
    Agrawal, Tanvi
    Ramakrishna, Gayatri
    Jindal, Ankur
    Sarin, Shiv K.
    Trehanpati, Nirupma
    HEPATOLOGY, 2017, 66 : 795A - 795A
12345